How Peptide Purity Is Tested: HPLC, Mass Spectrometry, and What to Look for in a CoA

When you purchase research peptides, you’re trusting that the compound in the vial matches the label. The only way to verify that is through analytical testing — and the two methods you’ll see cited most often are HPLC and mass spectrometry.

Understanding what these tests actually measure, what good results look like, and how to read a Certificate of Analysis (CoA) will help you evaluate suppliers and make better decisions about the compounds entering your research workflow.

---

Why Purity Testing Matters

Impure peptides introduce noise into research. If your vial contains 85% target peptide and 15% truncated sequences, deletion peptides, or synthesis byproducts, your dose calculations are wrong, your results are confounded, and your conclusions may not replicate.

At research scale, this matters both for data quality and for reproducibility. When two labs get different results studying the same compound, impurity profiles are often part of the explanation.

---

HPLC: Measuring Purity by Separation

High-Performance Liquid Chromatography (HPLC) separates the components of a mixture based on their interaction with a stationary phase (typically a silica-based column) and a mobile phase (a flowing solvent system).

For peptides, reversed-phase HPLC (RP-HPLC) is standard. In RP-HPLC:

• The column surface is hydrophobic
• Components are eluted by gradually increasing the organic solvent concentration in the mobile phase
• More hydrophobic compounds spend more time interacting with the column and elute later
• The detector (typically UV absorbance at 214–220 nm, which captures peptide bonds) generates a signal as each component passes through

What the Chromatogram Shows

The result is a trace — peaks over time. The target peptide produces the largest peak. Everything else produces smaller peaks.

Purity (%) = (Area of main peak) / (Total area of all peaks) × 100

For research-grade peptides, you want to see:

• ≥ 98% purity — Standard benchmark for research applications
• One dominant, sharp peak — Clean elution profile
• Minimal secondary peaks — Any significant secondary peaks represent impurities (synthesis truncations, oxidized variants, aggregates)

What HPLC Doesn’t Tell You

HPLC tells you how pure something is. It doesn’t tell you what it is. A vial could be 99% pure and still contain the wrong compound. HPLC purity is necessary but not sufficient — you need mass spectrometry to confirm identity.

---

Mass Spectrometry: Confirming Identity

Mass spectrometry (MS) measures the mass-to-charge ratio (m/z) of ionized molecules. For peptide verification, the key measurement is the molecular mass of the compound.

The process:

1. The peptide is ionized (typically by electrospray ionization, ESI, or MALDI)
2. The ionized molecule is accelerated through a magnetic field
3. The detector records how ions separate based on their mass-to-charge ratios
4. The output is a spectrum showing peaks at specific m/z values

What to Look For

For each peptide, there’s a calculated molecular weight based on the amino acid sequence and any modifications. The MS result should show a molecular ion peak that matches this calculated value within acceptable tolerance (typically ± 1 Da for unmodified peptides; larger for peptides with fatty acid modifications due to isotope envelope complexity).

Example: A peptide with a calculated MW of 4113.58 Da should produce a molecular ion at approximately 4113 Da, plus expected charge state series (for ESI, you’ll typically see [M+2H]²⁺, [M+3H]³⁺, etc.).

MS for GLP-Class Peptides

GLP-class peptides (GLP1 Sema, GLP2 Tirz, GLP3 Reta) are larger molecules with fatty acid side chain modifications. Their MS analysis is more complex:

• Molecular weights in the 4,000–5,000+ Da range
• Fatty acid chains add mass in predictable increments
• The isotope envelope for larger molecules spans multiple m/z values; the monoisotopic and average masses need to be distinguished

A complete MS report for these compounds typically includes the deconvoluted average mass alongside the raw spectrum.

---

Reading a Certificate of Analysis (CoA)

A CoA is the document that should accompany every peptide lot. Here’s what a quality CoA includes:

1. Compound Identification

• Name (or research code)
• Lot number — critical for traceability
• CAS number (if applicable)
• Molecular formula and molecular weight

2. HPLC Data

• Purity percentage
• Chromatogram (ideally included, not just the number)
• Method conditions (column type, gradient, detection wavelength)

3. Mass Spectrometry Data

• Observed molecular mass
• Expected/theoretical molecular mass
• Spectrum (ideally included)

4. Additional Tests (Quality Tier Dependent)

• Moisture content (Karl Fischer titration) — important for accurate dosing calculations, as lyophilized peptides can absorb atmospheric moisture
• Residual solvents — Tests for DMSO, acetonitrile, or TFA residues from synthesis
• Endotoxin testing (LAL assay) — Critical if you’re working with in vivo models; endotoxin contamination confounds biological results profoundly
• Sterility — For any application involving injection into cell culture or organisms

5. Storage Conditions

• Recommended storage temperature
• Stability data if available

---

Red Flags in Supplier CoAs

Some CoAs look impressive but contain less information than they appear to. Watch for:

• Purity listed without a chromatogram — You want to see the actual trace, not just a number
• No mass spec data — Identity unconfirmed
• Lot number that doesn’t match your vial — Generic CoAs not tied to your specific lot
• No method details — “HPLC: 98%” without specifying conditions is not verifiable
• Unusually high purity claims (>99.9%) — While achievable, very high claims without supporting data warrant scrutiny

---

Third-Party Testing

The gold standard is third-party testing — where an independent analytical lab tests the peptide and generates the CoA, rather than the manufacturer testing their own product.

Third-party CoAs are more credible because:

• No incentive to round up or overlook impurities
• Standardized methods and calibration
• Chain of custody documentation

Progression Peptides provides third-party tested peptides with CoA documentation for each lot. When evaluating any peptide supplier, asking directly about their testing methodology and whether CoAs are first-party or third-party is a reasonable and appropriate question.

---

Summary

HPLC and mass spectrometry together answer two distinct questions: how pure? and is it the right compound? Both are necessary for meaningful research-grade verification. When evaluating peptide suppliers, the quality and completeness of the CoA documentation is one of the most useful signals available.

---

This article is intended for educational purposes for researchers working with peptides in a laboratory setting. All peptides sold by Progression Peptides are for research use only — not for human consumption, clinical use, or therapeutic application. This content does not constitute medical advice.